gerd
TRANSCRIPT
![Page 1: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/1.jpg)
Current Trends and Updates on Diagnosis and Management of
GERDJeraldine S. Orlina, MD
Grand RoundsJanuary 11, 2006
![Page 2: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/2.jpg)
Pathophysiology• Lower esophageal sphincter
• Intrinsic muscle of distal esophagus
• Sling fibers of cardia• Diaphragm• Transmitted pressure
of abdominal cavity
• Reflux occurs when the high-pressure zone in distal esophagus is too low or when sphincter with normal pressure undergoes spontaneous relaxation
![Page 3: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/3.jpg)
![Page 4: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/4.jpg)
Absite Question• An operation is the primary initial
management for:• A) Achalasia• B) a large sliding esophageal hiatal
hernia• C) an epiphrenic esophageal
diverticulum• D) gastroesophageal reflux• E) a paraesophageal hiatal hernia
![Page 5: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/5.jpg)
SymptomsSymptom Predominance (%)Heartburn 80Regurgitation 54Abdominal Pain 29Cough 27Dysphagia for solids 23Hoarseness 21Belching 15Aspiration 14Wheezing 7Globus 4
![Page 6: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/6.jpg)
Symptoms -- Heartburn• Epigastric and retrosternal• Caustic or stinging sensation• Does not radiate to the back, is not
pressurelike• Can be confused with symptoms of
PUD, bilary colic, or CAD
![Page 7: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/7.jpg)
Symptoms -- Regurgitation• Indicates progression of disease• Distinguish between digested and
undigested food
![Page 8: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/8.jpg)
Diagnostic Studies• Empirical Therapy• Upper Gastrointestinal Endoscopy
(EGD)• Upper Gastrointestinal Fluoroscopy
with Barium• 24-hour pH testing• Esophageal Manometry
![Page 9: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/9.jpg)
EGD• Allows examination of the
esophageal mucosa• Identifies presence of esophagitis
and grading of severity• Can identify other pathology, such as
diverticula, hiatal hernia, webs, rings, or strictures
• Tissue biopsies to screen for Barrett’s esophagus
![Page 10: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/10.jpg)
Absite Question• Four hours following upper
esophagogastric endoscopy for gastroesophageal reflux, a 62 year-old man returns to the emergency room with chills, chest pain, and dyspnea. Cardiac work-up is normal, but esophagography shows a distal esophageal perforation. The most appropriate management is• A) nasogastric suction and TPN• B) reinforced primary esophageal repair• C) drainage and esophageal diversion• D) esophagectomy with gastric pull-through• E) fluoroscopic esophageal stent placement
![Page 11: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/11.jpg)
Absite Question• A 60 year-old otherwise healthy man
has symptomatic GERD that has not responded to medical therapy, including PPIs. Esophagoscopy shows moderately severe esophagitis. Multiple biopsies of the esophageal mucosa in the area of esophagitis show columnar epithelium replacing the normal squamous epithelium. As the patient’s treatment is being planned, a biopsy report shows high-grade dysplasia.
![Page 12: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/12.jpg)
(cont)• Treatment should be
A. Continued medical treatment with yearly esophagoscopy and biopsies
B. Laparoscopic Nissen fundoplicationC. Photodynamic therapyD. EsophagectomyE. Laser ablation of normal mucosa
![Page 13: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/13.jpg)
24-hour pH test• Gold Standard for
presence of pathologic reflux
• Parameters measured include: total # of reflux episodes, duration of longest reflux episode, percentage of time pH is less than 4
![Page 14: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/14.jpg)
Ambulatory pH testing – Recent Advances
• Combined impedance and acid testing• Allows for the
measurement of both acid and nonacid (volume) reflux.
• Important in pt with persistent symptoms despite an adequate medical trial
![Page 15: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/15.jpg)
Ambulatory pH testing – Recent Advances• Tubeless method–
Bravo System• Allows a radiotelemetry
capsule to be attached to the esophageal mucosa
• Decreases patient discomfort, allows for longer (48h) monitoring, and may improve accuracy by allowing the patient to carry out their usual activities
![Page 16: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/16.jpg)
![Page 17: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/17.jpg)
Esophageal Manometry• Lower Esophageal
Sphincter (LES)• Mean resting
pressure• Total length
• Esophageal Body• To determine
effectiveness of peristalsis
• Amplitude of esophageal wave
![Page 18: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/18.jpg)
Esophagram• Useful when
operation is planned—shows anatomy of esophagus and proximal stomach
• Demonstrates presence and size of hiatal hernia if present
![Page 19: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/19.jpg)
Treatment – Lifestyle Modification• May benefit many patients with
GERD, although these changes alone are unlikely to control symptoms in the majority of patients
• Elevation of the head of the bed, decreased fat intake, cessation of smoking, avoiding recumbency for 3h postprandially, avoidance of certain foods (chocolate, EtOH, peppermint)
• No data reflecting the efficacy of these maneuvers
![Page 20: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/20.jpg)
Treatment – Patient Directed Therapy
• Antacids • H2 receptor antagonists• If symptoms persist, continuous
therapy is required, or alarm symptoms/signs develop – pt should have additional evaluation and treatment
![Page 21: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/21.jpg)
Treatment – Acid Suppression• 6-week course of acid-suppression
therapy• Double dose of a proton pump
inhibitor• Irreversible bind the proton pump in
parietal cells of the stomach• Maximal effect 4 days after initiation of
therapy and lasts for the life of the parietal cell
• More effective than other antacid regimens
![Page 22: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/22.jpg)
Absite Question• Proton pump inhibitors used in the
treatment of GERDA. Cause regression of Barrett’s
epitheliumB. Inhibit progression of dysplasiaC. Increase squamous islands in Barrett’s
segmentsD. Reverse intestinal metaplasiaE. Are effective only if gastric acidity is
normalized
![Page 23: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/23.jpg)
Treatment – Promotility Therapy• May be used as an adjunct to acid
suppression therapy in patients with demonstrated defects in esophagogastric motility (LES incompetence, poor esophageal clearance, delayed gastric emptying)
![Page 24: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/24.jpg)
Absite Question• Five years after a myocardial infarction, a 55
year-old woman with HTN and DM has symptomatic esophagogastric reflux. Medical treatment for the last year has not been successful. Her BMI is 55. Esophagoscopy shows severe esophagitis. Multiple biopsies show inflammatory changes but no columnar epithelium or cancer. The best treatment would be:
A. Nissen fundoplicationB. Gastric bypass procedureC. Gastric banding procedureD. Vertical banded gastroplastyE. Biliary-pancreatic diversion with duodenal switch
![Page 25: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/25.jpg)
Surgical Therapy• Indications
• Pt w/ evidence of severe esophageal injury (ulcer, stricture, or Barrett’s)
• Incomplete resolution of symptoms or relapses while on medical therapy
• Long duration of symptoms• Younger patients• Ideal patient: more than 10-year life
expectancy and are in need of lifelong therapy due to a mechanically defective sphincter
![Page 26: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/26.jpg)
Copyright ©2004 CMA Media Inc. or its licensors
Urbach, D. R. et al. CMAJ 2004;170:219-221
Trends in the use of surgery for gastroesophageal reflux disease in Ontario, 1988-2000
![Page 27: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/27.jpg)
Laparoscopic Nissen Fundoplication
• Lafullarde T, Watson DI, Jamieson GG, Myers JC, Game PA, Devitt PG. Laparoscopic Nissen fundoplication: five-year results and beyond. Arch Surg. 2001 Feb;136(2):180-4 • 87% of the 176 patients remained free
of significant reflux. The long-term outcome was considered "good or excellent" by 90% of patients.
![Page 28: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/28.jpg)
Laparoscopic Nissen Fundoplication
• Success rate of greater than 90%• Procedure of choice
![Page 29: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/29.jpg)
![Page 30: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/30.jpg)
![Page 31: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/31.jpg)
![Page 32: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/32.jpg)
![Page 33: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/33.jpg)
![Page 34: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/34.jpg)
![Page 35: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/35.jpg)
![Page 36: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/36.jpg)
Absite Question• A 56 year-old man is seen 2 years after
a laparoscopic Nissen fundoplication for GERD. His pre-operative work-up 2 years ago demonstrated normal esophageal motility, and pH probe testing showed that reflux was the cause of his symptoms. He now has recurrent symptoms of GE reflux.
A Barium swallow is performed.
![Page 37: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/37.jpg)
• Which is not true about this patient?A. Redo operation is as
effective as primary antireflux operation for ameliorationg reflux symptoms
B. Transabdominal laparoscopic redo operation is contraindicated
C. Redo operation has an increased complication rate
D. The cause is related to technical performance of the initial operation
E. Manometry is helpful in planning operative therapy
![Page 38: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/38.jpg)
Absite Question• Four years ago, a 47 year-old woman had a
laparoscopic fundoplication. It failed after three years and she had severe, recurrent gastroesophageal symptoms. Through a celiotomy incision, the surgeon performed a redo-fundoplication with a 360-degree, 2 cm wrap around a 56 Fr dilator. For the past three months she has had severe early satiety, postprandial epigastric pain, and weight loss. The most likely cause of these symptoms is:A. The wrap is too tightB. The wrap is too looseC. Vagal injuryD. Irritable bowel syndromeE. Esophageal motor disorder
![Page 39: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/39.jpg)
Absite Question• Barrett’s esophagus
• A) will usually regress after Nissen fundoplication
• B) carries an increased risk of squamous cell carcinoma
• C) is an indication for esophagectomy• D) should be followed by endoscopic
surveillance• E) is a contraindication to laparoscopic
Nissen fundoplication
![Page 40: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/40.jpg)
Endoscopic Therapy• Attempt to augment the LES by
1. Suturing – EndoCinch2. Radiofrequency energy – Stretta3. Plexiglass injection –
polymethylmethacrylate4. Biocompatible polymer injection --
Enteryx
![Page 41: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/41.jpg)
Plication/Sewing Techniques• First developed in the mid ’80’s• Allow placement of sutures into the
gastric cardia, thereby augmenting the barrier effect of the GEJ
• Bard EndoCinch
![Page 42: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/42.jpg)
![Page 43: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/43.jpg)
EndoCinch• Filipi CJ, Lehman GA, Rothstein RI et
al. “Transoral, flexible endoscopic suturing for treatment of GERD: a multicenter trial.” Gastrointestinal Endoscopy 2001; 53: 416-22.• Suggested that endoscopic gastric
plication is a safe procedure and, at a 6-month follow-up, that 2/3 of pts undergoing the procedure were successfully treated.
![Page 44: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/44.jpg)
EndoCinch (cont)• Inclusion Criteria
• Three or more episodes of heartburn a week when off antisecretory meds
• Successful response to and reliance upon antisecretory meds for GERD
• Abnormal acid reflux on ambulatory pH monitoring
• Exclusion Criteria• Dysphagia• BMI greater than 40• GERD refractory to PPIs• Hiatal hernia greater than 2 cm in length
![Page 45: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/45.jpg)
EndoCinch (cont)• Treatment success defined as a decrease
in the heartburn severity score by 50% in addition to a reduction in the use of antireflux medications to fewer to 4 doses per month.
• 64 patients were enrolled• 33 pts (52%) – gastroplication in a linear
configuration• 31 (48%) – gastroplication in a circumferential
plication• No difference in outcomes between the 2
groups
![Page 46: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/46.jpg)
• Results:• Mean heartburn scores fell from a preprocedure
score of 62.7 to mean scores of 16.7 and 17 and 3 and 6 months postprocedure
• Percent total time the pH was < 4, total number of reflux episodes, and percent upright pH time was lower than 4 were all significantly improved, but none returned to normal range
• Regurgitation scores improved significantly• Quality of life scores were improved for social
functioning and bodily pain and 62% of pts at 3 and 6 month f/u were taking less than 4 doses of medication per month
![Page 47: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/47.jpg)
• Results (cont)• No significant change found in LES
resting pressure or length• No significant effect on mucosal healing• Adverse events included pharyngitis
(31%), vomiting (14%), and abdominal pain (14%), and chest pain (16%)
• One patient experienced a suture microperforation that was treated conservatively with IV antibiotics and brief hospitalization
![Page 48: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/48.jpg)
EndoCinch (cont) • Chen YK, Raijman I, Ben-Menachem T
et al. “Long-term outcomes of endoluminal gastroplication: a U.S. multicenter trial.” Gastrointestinal Endoscopy 2003. 61: 434-440• Prospective, multicenter trial which
enrolled 85 patients to be treated with endoluminal gastroplication followed over 2 years
![Page 49: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/49.jpg)
• Results:• 51% of patients had no or occasional GERD
symptoms• 73% and 69% were completely off PPIs or at 12
and 24 months postprocedure• Reduction in the mean annual medication cost
from $1564 per year preprocedure to $157 one year postprocedure (cost redux of 88%)
• Shortcomings of study• Does not contain a
nonplication sham group• Trends toward increased
symptoms over time suggestive of degradation of repair over time
![Page 50: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/50.jpg)
EndoCinch (cont)• Schiefke I et al. “Long term failure of
endoscopic gastroplication (EndoCinch)”. Gut 2005; 54: 752-758• Evaluated prospectively long term
outcome after EndoCinch• 70 patients at a single referral center• Patients interviewed with a standard
questionaire regarding symptoms, medication use, in addition to f/u with endoscopy, 24h pH monitoring, and esophageal manometry
![Page 51: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/51.jpg)
• Results:• 18 months after EndoCinch 56/70
patients (80%) were considered treatment failures as their heartburn symptoms did not improve or PPI medication exceeded 50% of initial dose
• Endoscopy showed all sutures in situ in 12/70 (17%), while no sutures remained in 18/70 (26%)
• No significant changes in 24h pH monitoring or LES pressure
![Page 52: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/52.jpg)
• Conclusion:• Long term outcome is disappointing
probably due to suture loss in the majority of patients
![Page 53: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/53.jpg)
Radiofrequency Thermal Therapy -- Stretta
• Delivery of low-power, temperature-controlled radiofrequency energy to the GEJ
• Two mechanisms1. mechanically altering the GEJ2. inducing the ablation of nerves that trigger transient lower esophageal relaxation
![Page 54: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/54.jpg)
Radiofrequency Thermal Therapy -- Stretta
![Page 55: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/55.jpg)
Stretta• Wolfsen HC and Richards WO. “The
Stretta Procedure for the Treatment of GERD: A registry of 558 patients.” Journal of Laparoendoscopic and Advanced Surgical Techniques 2002• 558 patients, 33 institutions• 6 months of follow-up• Survey administered which assessed
GERD severity, percentage of GERD symptom control, satisfaction, and antisecretory medication use
![Page 56: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/56.jpg)
• Results• At baseline, the median percentage of
GERD symptom control while on drugs was 50%, compared with 90% after Stretta
• Satisfaction with symptom control was 26% versus 77% after Stretta
• Median requirement at baseline was double dose of PPI versus antacids prn after Stretta
• Most subjects (90%) would recommend Stretta to a friend
![Page 57: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/57.jpg)
Stretta• Triadafilopolous et al: reported 6- and
12- month results of an open label trial of Stretta• Prospective multicenter trial involving 118
patients who had chronic heartburn or regurgitation, abnormal esophageal acid exposure, hiatal hernia less than 2 cm, and mild esophagitis
• At 12 mo: improvement in heartburn score, GERD score, and quality of life. PPI use decreased from 88% to 30%. Esophageal acid exposure improved significantly, although no improvement in the incidence and severity of esophagitis
![Page 58: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/58.jpg)
• randomized, double-blinded, sham controlled trial of radiofrequency energy to the gastroesophageal junction for the treatment of GERD
![Page 59: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/59.jpg)
Patient Criteria• heartburn or acid regurgitation at least partially
responsive to and requiring daily antacid medications
• age 18 years• 24-hour pH study (off medications) showing
abnormal esophageal acid exposure (4%) or a DeMeester score of 14.7
• esophageal manometry showing normal esophageal peristalsis and sphincter relaxation
• EGD, on medications, showing no esophagitis worse than grade II (i.e., no substantial ulcerations), no hiatal hernia 2 cm long, and no Barrett’s esophagus
• no coagulation disorders, mechanical prostheses, prominent dysphagia, or unstable disorders.
![Page 60: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/60.jpg)
![Page 61: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/61.jpg)
![Page 62: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/62.jpg)
Stretta
• Patients were offered the Stretta procedure if they had documented GERD and did not have a hiatal hernia larger than 2 cm, LES pressure less than 8 mmHg, or Barrett’s esophagus.
• Patients with larger hiatal hernias, LES pressure less than 8 mmHg, or Barrett’s were offered LF.
![Page 63: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/63.jpg)
![Page 64: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/64.jpg)
![Page 65: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/65.jpg)
![Page 66: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/66.jpg)
![Page 67: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/67.jpg)
Stretta• Conclusions – Although the incidence
of complications is decreased compared with operative intervention, success of therapy does not approach that of surgical intervention
• After Stretta 30-50% of patients still require PPI therapy
![Page 68: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/68.jpg)
![Page 69: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/69.jpg)
Injection/implantation techniques -- Enteryx
• Injectable biocompatible solution consisting of 8% ethylene vinyl alcohol copolymer mixed in dimethyl sulfoxide
• When injected into the LES, the solution interacts with the surrounding fluid to become an inert spongy solid mass
• Mechanism: may impart an alteration in the compliance of tissues preventing sphincter shortening and improving the barrier function of the GEJ
![Page 70: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/70.jpg)
Enteryx
![Page 71: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/71.jpg)
Enteryx• Cohen LB, Johnson DA, Ganz RA et al
“Enteryx implantation for GERD: expanded multicenter trial results and interim postapproval follow-up to 24 months.” Gastrointestinal Endoscopy May 2005• Open-label, international clinical trial
conducted in 144 PPI—dependent patients with GERD with f/u at 6 and 12 months
• Primary outcome: PPI use• Secondary outcome: GERD health-related
quality of life and esophageal acid exposure
![Page 72: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/72.jpg)
• Results:• At 12 months PPI use was reduced by
greater than 50% in 84% of treated pts
• GERD health-related quality of life < 11% in 78% of patients
• Esophageal acid exposure was reduced by 31%
![Page 73: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/73.jpg)
Enteryx
![Page 74: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/74.jpg)
Conclusions on Endoscopic Mgmt of GERD
• Techniques need to be further studied in sham-controlled protocol
• Long term follow-up suggest a declining effect of treatment with pts returning to PPI use -- more long term f/u studies necessary
• Future studies should improve targeting of which patients benefit, further elucidate the mechanisms of action, and provide detailed comparisons to alternative treatments.
![Page 75: gerd](https://reader033.vdocuments.us/reader033/viewer/2022061120/546d7a58b4af9f58588b45f7/html5/thumbnails/75.jpg)
Future of Endoscopic Therapy• As a substitute for long-term medical
therapy for the pt with mildly symptomatic GERD
• As adjuncts to ongoing pharmacologic treatment
• In patients with a failed surgical fundoplication